← Back to patent-cliff list
Nitrosooxypropanol
Tier C — Watch / tradeNitrosooxypropanol
Attgeno AB
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：GC
Indications (approved)：Pulmonary hypertension, Arterial occlusive disease, Pulmonary arterial hypertension, Pulmonary embolism, Infectious disease, Neoplasm
Regional status
US
-
EU
Phase II
2022-10-23
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Nitrosooxypropanol?
Approved indications include: Pulmonary hypertension, Arterial occlusive disease, Pulmonary arterial hypertension, Pulmonary embolism, Infectious disease, Neoplasm.
When does the Nitrosooxypropanol patent expire?
No public expiry year is available for Nitrosooxypropanol yet; this page updates once verified.
How do I get a quote for Nitrosooxypropanol intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-03